Publications: Dr Louisa Dunmall
Xu L, Wang J, Zhang D, Song L, Wu H, Wang J, Miao J, Guo H et al.
(
2022
)
.
The two-faced role of ATF2 on cisplatin response in gastric cancer depends on p53 context
.
Cell & Bioscience
vol.
12
,
(
1
)
Lu S, Zhang Z, Du P, Chard LS, Yan W, El Khouri M, Wang Z, Zhang Z et al.
(
2021
)
.
Correction: A Virus-infected, Reprogrammed Somatic Cell–derived Tumor Cell (VIReST) Vaccination Regime can Prevent Initiation and Progression of Pancreatic Cancer
.
Clinical Cancer Research
vol.
27
,
(
9
)
2663
-
2663
.
(
2020
)
.
Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
.
Journal for ImmunoTherapy of Cancer
vol.
8
,
(
1
)
Ahmed J, Chard LS, Yuan M, Wang J, Howells A, Li Y, Li H, Zhang Z et al.
(
2020
)
.
A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
.
Journal for ImmunoTherapy of Cancer
vol.
8
,
(
1
)
Lu S, Zhang Z, Du P, Chard LS, Yan W, Khouri ME, Wang Z, Zhang Z et al.
(
2020
)
.
A Virus-Infected, Reprogrammed Somatic Cell–Derived Tumor Cell (VIReST) Vaccination Regime Can Prevent Initiation and Progression of Pancreatic Cancer
.
Clinical Cancer Research
vol.
26
,
(
2
)
465
-
476
.
Miao J, Chard LS, Wang Z, Wang Y
(
2019
)
.
Syrian Hamster as an Animal Model for the Study on Infectious Diseases
.
Frontiers in Immunology
vol.
10
,
Wang P, Li X, Wang J, Gao D, Li Y, Li H, Chu Y, Zhang Z et al.
(
2018
)
.
Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
.
Nature Communications
vol.
9
,
(
1
)
Wang P, Li X, Wang J, Gao D, Li Y, Li H, Chu Y, Zhang Z et al.
(
2017
)
.
Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
.
Nat Commun
vol.
8
,
(
1
)
1395
-
1395
.
Yuan M, Wang P, Chard LS, Lemoine NR, Wang Y
(
2016
)
.
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
.
Journal of Visualized Experiments
(
116
)
Yuan M, Wang P, Chard LS, Lemoine NR, Wang Y
(
2016
)
.
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
.
Journal of Visualized Experiments
(
116
)
Yuan M, Gao X, Chard LS, Ali Z, Ahmed J, Li Y, Liu P, Lemoine NR et al.
(
2015
)
.
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
.
Molecular Therapy — Methods & Clinical Development
vol.
2
,
Chard LS, Lemoine NR, Wang Y
(
2015
)
.
New role of Interleukin-10 in enhancing the antitumor efficacy of oncolytic vaccinia virus for treatment of pancreatic cancer
.
OncoImmunology
vol.
4
,
(
9
)
Ahmed J, Yuan M, Li Y, Chu Y, Zhang Z, Gao D, Chard LS, Alusi G et al.
(
2015
)
.
420. A Promising Neo-Adjuvant Immuno-Therapeutic Agent for Preventing Cancer Recurrence and Metastasis After Surgery
.
Molecular Therapy
.
vol.
23
,
Yuan M, Zhang W, Wang J, Al Yaghchi C, Ahmed J, Chard L, Lemoine NR, Wang Y
(
2015
)
.
Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 System
.
Journal of Virology
vol.
89
,
(
9
)
5176
-
5179
.
Chard LS, Maniati E, Wang P, Zhang Z, Gao D, Wang J, Cao F, Ahmed J et al.
(
2015
)
.
A Vaccinia Virus Armed with Interleukin-10 Is a Promising Therapeutic Agent for Treatment of Murine Pancreatic Cancer
.
Clinical Cancer Research
vol.
21
,
(
2
)
405
-
416
.
Hiley CT, Chard L, Tysome J, Briat A, Lemoine NR, Wang Y
(
2012
)
.
Abstract A37: Increased efficacy of oncolytic vaccinia virus, an emerging therapy for pancreatic adenocarcinoma, due to intratumoral hypoxia and vascular endothelial growth factor A
.
Conference:
Therapya37
-
a37
.
Ahmed J, Yuan M, Li Y, Chu Y, Shi H, Chard L, Alusi G, Lemoine N et al.
(
2014
)
.
A Novel Tumour Selective Oncolytic Vaccinia Virus Lacking the N1L Gene Enhances the Anti-Tumour Immune Response When Used as an Anticancer Therapeutic
.
MOLECULAR THERAPY
.
vol.
22
,
S248
-
S249
.
Hiley CT, Chard LS, Gangeswaran R, Tysome JR, Briat A, Lemoine NR, Wang Y
(
2013
)
.
Vascular endothelial growth factor A promotes vaccinia virus entry into host cells via activation of the Akt pathway
.
J Virol
vol.
87
,
(
5
)
2781
-
2790
.
Chard LS, Maniati E, Wang P, Hughes J, Wang J, Denes B, Fodor I, Hagemann T et al.
(
2013
)
.
A Vaccinia Virus Armed with Interleukin-10 That Dampens Host Immunity to the Vctor but Not to Tumor Is a Promising Therapeutic Agent for Pancreatic Cancer
.
MOLECULAR THERAPY
.
vol.
21
,
S196
-
S196
.
Tysome JR, Li X, Wang S, Wang P, Gao D, Du P, Chen D, Gangeswaran R et al.
(
2012
)
.
A novel therapeutic regimen to eradicate established solid tumors with an effective induction of tumor-specific immunity
.
Clin Cancer Res
vol.
18
,
(
24
)
6679
-
6689
.
Wang P, Jiang G, Chard L, Wang J, Gao D, Cao H, Lemoine NR, Wang Y
(
2012
)
.
A Rationally Designed Oncolytic Adenovirus, Ad-TD-IL-12, Cures Pancreatic Cancer in the Immunocompetent Syrian Hamster
.
MOLECULAR THERAPY
.
vol.
20
,
S131
-
S131
.
Hiley CT, Chard L, Lemoine N, Wang Y
(
2011
)
.
A novel replication-selective vaccinia virus vector to express diagnostic or therapeutic genes in hypoxic environments
.
HUMAN GENE THERAPY
vol.
22
,
(
10
)
A99
-
A100
.
Chard LS, Bailey DS, Dash P, Banyard AC, Barrett T
(
2008
)
.
Full genome sequences of two virulent strains of peste-des-petits ruminants virus, the Côte d'Ivoire 1989 and Nigeria 1976 strains
.
Virus Res
vol.
136
,
(
1-2
)
192
-
197
.
Bailey D, Chard LS, Dash P, Barrett T, Banyard AC
(
2007
)
.
Reverse genetics for peste-des-petits-ruminants virus (PPRV): promoter and protein specificities
.
Virus Res
vol.
126
,
(
1-2
)
250
-
255
.
Bordeleau M-E, Mori A, Oberer M, Lindqvist L, Chard LS, Higa T, Belsham GJ, Wagner G et al.
(
2006
)
.
Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A
.
Nat Chem Biol
vol.
2
,
(
4
)
213
-
220
.
Chard LS, Bordeleau M-E, Pelletier J, Tanaka J, Belsham GJ
(
2006
)
.
Hepatitis C virus-related internal ribosome entry sites are found in multiple genera of the family Picornaviridae
.
J Gen Virol
vol.
87
,
(
Pt 4
)
927
-
936
.
Chard LS, Kaku Y, Jones B, Nayak A, Belsham GJ
(
2006
)
.
Functional analyses of RNA structures shared between the internal ribosome entry sites of hepatitis C virus and the picornavirus porcine teschovirus 1 Talfan
.
J Virol
vol.
80
,
(
3
)
1271
-
1279
.
Pisarev AV, Chard LS, Kaku Y, Johns HL, Shatsky IN, Belsham GJ
(
2004
)
.
Functional and structural similarities between the internal ribosome entry sites of hepatitis C virus and porcine teschovirus, a picornavirus
.
J Virol
vol.
78
,
(
9
)
4487
-
4497
.
Kaku Y, Chard LS, Inoue T, Belsham GJ
(
2002
)
.
Unique characteristics of a picornavirus internal ribosome entry site from the porcine teschovirus-1 talfan
.
J Virol
vol.
76
,
(
22
)
11721
-
11728
.